ANI PHARMACEUTICALS INC (ANIP) Fundamental Analysis & Valuation

NASDAQ:ANIP • US00182C1036

Current stock price

70.49 USD
-2 (-2.76%)
At close:
70.49 USD
0 (0%)
After Hours:

This ANIP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ANIP Profitability Analysis

1.1 Basic Checks

  • In the past year ANIP was profitable.
  • In the past year ANIP had a positive cash flow from operations.
  • In the past 5 years ANIP reported 4 times negative net income.
  • In multiple years ANIP reported negative operating cash flow during the last 5 years.
ANIP Yearly Net Income VS EBIT VS OCF VS FCFANIP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.42%, ANIP belongs to the top of the industry, outperforming 82.90% of the companies in the same industry.
  • ANIP has a better Return On Equity (6.75%) than 84.46% of its industry peers.
  • ANIP has a Return On Invested Capital of 5.61%. This is amongst the best in the industry. ANIP outperforms 83.42% of its industry peers.
Industry RankSector Rank
ROA 2.42%
ROE 6.75%
ROIC 5.61%
ROA(3y)-2.12%
ROA(5y)-3.36%
ROE(3y)-5.31%
ROE(5y)-7.87%
ROIC(3y)N/A
ROIC(5y)N/A
ANIP Yearly ROA, ROE, ROICANIP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • ANIP has a better Profit Margin (4.13%) than 82.38% of its industry peers.
  • ANIP has a better Operating Margin (9.77%) than 82.90% of its industry peers.
  • ANIP's Operating Margin has declined in the last couple of years.
  • ANIP's Gross Margin of 61.14% is fine compared to the rest of the industry. ANIP outperforms 70.98% of its industry peers.
  • ANIP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.77%
PM (TTM) 4.13%
GM 61.14%
OM growth 3YN/A
OM growth 5Y-47.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.51%
GM growth 5Y-3.12%
ANIP Yearly Profit, Operating, Gross MarginsANIP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ANIP Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ANIP is destroying value.
  • There is no outstanding debt for ANIP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ANIP Yearly Shares OutstandingANIP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ANIP Yearly Total Debt VS Total AssetsANIP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 2.17 indicates that ANIP is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ANIP (2.17) is better than 64.25% of its industry peers.
  • The Debt to FCF ratio of ANIP is 3.98, which is a good value as it means it would take ANIP, 3.98 years of fcf income to pay off all of its debts.
  • ANIP has a better Debt to FCF ratio (3.98) than 86.53% of its industry peers.
  • ANIP has a Debt/Equity ratio of 1.20. This is a high value indicating a heavy dependency on external financing.
  • ANIP has a worse Debt to Equity ratio (1.20) than 72.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF 3.98
Altman-Z 2.17
ROIC/WACC0.61
WACC9.23%
ANIP Yearly LT Debt VS Equity VS FCFANIP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 2.58 indicates that ANIP has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.58, ANIP is in line with its industry, outperforming 47.67% of the companies in the same industry.
  • A Quick Ratio of 2.04 indicates that ANIP has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.04, ANIP is in line with its industry, outperforming 48.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.04
ANIP Yearly Current Assets VS Current LiabilitesANIP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ANIP Growth Analysis

3.1 Past

  • ANIP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.35%, which is quite impressive.
  • ANIP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.59% yearly.
EPS 1Y (TTM)51.35%
EPS 3Y77.39%
EPS 5Y17.59%
EPS Q2Q%42.94%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%29.64%

3.2 Future

  • Based on estimates for the next years, ANIP will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.75% on average per year.
  • ANIP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.49% yearly.
EPS Next Y15.55%
EPS Next 2Y17.27%
EPS Next 3Y14.38%
EPS Next 5Y11.75%
Revenue Next Year19.62%
Revenue Next 2Y17.68%
Revenue Next 3Y13.55%
Revenue Next 5Y11.49%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ANIP Yearly Revenue VS EstimatesANIP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
ANIP Yearly EPS VS EstimatesANIP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

More info and screens

Find the best growth stocksShow best growing peers

8

4. ANIP Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.96, the valuation of ANIP can be described as very reasonable.
  • ANIP's Price/Earnings ratio is rather cheap when compared to the industry. ANIP is cheaper than 92.23% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.70, ANIP is valued rather cheaply.
  • ANIP is valuated cheaply with a Price/Forward Earnings ratio of 7.75.
  • 91.19% of the companies in the same industry are more expensive than ANIP, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. ANIP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.96
Fwd PE 7.75
ANIP Price Earnings VS Forward Price EarningsANIP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • ANIP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ANIP is cheaper than 86.01% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ANIP indicates a rather cheap valuation: ANIP is cheaper than 89.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.15
EV/EBITDA 11.41
ANIP Per share dataANIP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • ANIP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ANIP's earnings are expected to grow with 14.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)0.51
EPS Next 2Y17.27%
EPS Next 3Y14.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ANIP Dividend Analysis

5.1 Amount

  • No dividends for ANIP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ANIP Fundamentals: All Metrics, Ratios and Statistics

ANI PHARMACEUTICALS INC

NASDAQ:ANIP (3/13/2026, 8:09:50 PM)

After market: 70.49 0 (0%)

70.49

-2 (-2.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-27
Earnings (Next)05-07
Inst Owners96.24%
Inst Owner Change2.97%
Ins Owners6.27%
Ins Owner Change-0.94%
Market Cap1.58B
Revenue(TTM)N/A
Net Income(TTM)34.14M
Analysts84.29
Price Target111.91 (58.76%)
Short Float %17.92%
Short Ratio7.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP4.58%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.16%
Min EPS beat(2)14.04%
Max EPS beat(2)24.28%
EPS beat(4)4
Avg EPS beat(4)17.56%
Min EPS beat(4)11.36%
Max EPS beat(4)24.28%
EPS beat(8)8
Avg EPS beat(8)16.28%
EPS beat(12)12
Avg EPS beat(12)41.62%
EPS beat(16)13
Avg EPS beat(16)13.52%
Revenue beat(2)2
Avg Revenue beat(2)7.37%
Min Revenue beat(2)5.83%
Max Revenue beat(2)8.9%
Revenue beat(4)4
Avg Revenue beat(4)7.06%
Min Revenue beat(4)5.83%
Max Revenue beat(4)8.9%
Revenue beat(8)8
Avg Revenue beat(8)5.8%
Revenue beat(12)12
Avg Revenue beat(12)9.19%
Revenue beat(16)15
Avg Revenue beat(16)7.44%
PT rev (1m)0%
PT rev (3m)0.52%
EPS NQ rev (1m)-0.62%
EPS NQ rev (3m)-1.91%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)1.26%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)0.06%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE 8.96
Fwd PE 7.75
P/S 1.91
P/FCF 10.15
P/OCF 9.26
P/B 3.12
P/tB N/A
EV/EBITDA 11.41
EPS(TTM)7.87
EY11.16%
EPS(NY)9.09
Fwd EY12.9%
FCF(TTM)6.95
FCFY9.85%
OCF(TTM)7.61
OCFY10.8%
SpS36.88
BVpS22.56
TBVpS-2.52
PEG (NY)0.58
PEG (5Y)0.51
Graham Number63.21
Profitability
Industry RankSector Rank
ROA 2.42%
ROE 6.75%
ROCE 7.1%
ROIC 5.61%
ROICexc 7.37%
ROICexgc 21.01%
OM 9.77%
PM (TTM) 4.13%
GM 61.14%
FCFM 18.83%
ROA(3y)-2.12%
ROA(5y)-3.36%
ROE(3y)-5.31%
ROE(5y)-7.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-44.22%
ROICexc growth 3YN/A
ROICexc growth 5Y-46.62%
OM growth 3YN/A
OM growth 5Y-47.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.51%
GM growth 5Y-3.12%
F-Score7
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF 3.98
Debt/EBITDA 3.51
Cap/Depr 16.39%
Cap/Sales 1.81%
Interest Coverage 2.94
Cash Conversion 99.13%
Profit Quality 456.13%
Current Ratio 2.58
Quick Ratio 2.04
Altman-Z 2.17
F-Score7
WACC9.23%
ROIC/WACC0.61
Cap/Depr(3y)17.9%
Cap/Depr(5y)14.57%
Cap/Sales(3y)2.42%
Cap/Sales(5y)2.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.35%
EPS 3Y77.39%
EPS 5Y17.59%
EPS Q2Q%42.94%
EPS Next Y15.55%
EPS Next 2Y17.27%
EPS Next 3Y14.38%
EPS Next 5Y11.75%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%29.64%
Revenue Next Year19.62%
Revenue Next 2Y17.68%
Revenue Next 3Y13.55%
Revenue Next 5Y11.49%
EBIT growth 1Y279.28%
EBIT growth 3YN/A
EBIT growth 5Y-34.31%
EBIT Next Year49.94%
EBIT Next 3Y29.56%
EBIT Next 5Y22.28%
FCF growth 1Y159.17%
FCF growth 3Y297.63%
FCF growth 5Y4.15%
OCF growth 1Y144.51%
OCF growth 3Y168.16%
OCF growth 5Y7.01%

ANI PHARMACEUTICALS INC / ANIP Fundamental Analysis FAQ

What is the fundamental rating for ANIP stock?

ChartMill assigns a fundamental rating of 5 / 10 to ANIP.


Can you provide the valuation status for ANI PHARMACEUTICALS INC?

ChartMill assigns a valuation rating of 8 / 10 to ANI PHARMACEUTICALS INC (ANIP). This can be considered as Undervalued.


Can you provide the profitability details for ANI PHARMACEUTICALS INC?

ANI PHARMACEUTICALS INC (ANIP) has a profitability rating of 5 / 10.


How financially healthy is ANI PHARMACEUTICALS INC?

The financial health rating of ANI PHARMACEUTICALS INC (ANIP) is 5 / 10.


How sustainable is the dividend of ANI PHARMACEUTICALS INC (ANIP) stock?

The dividend rating of ANI PHARMACEUTICALS INC (ANIP) is 0 / 10 and the dividend payout ratio is 4.58%.